Translation and Validation of the Standardized Cosmesis and Health Nasal Outcomes Survey in Dutch

Objective: The Standardized Cosmesis and Health Nasal Outcomes Survey is a validated instrument for patients undergoing rhinoplasty surgery. The aim of this study was to validate a Dutch-language version of the Standardized Cosmesis and Health Nasal Outcomes Survey.Methods: The Standardized Cosmesis and Health Nasal Outcomes Survey was translated and back-translated and 10 Dutch-speaking rhinoplasty patients were interviewed to evaluate the translation. The translated version was administered to 25 rhinoplasty patients (cases) and 25 controls at 2-week intervals. The internal consistency, test–retest reliability, and factor structure of Standardized Cosmesis and Health Nasal Outcomes Survey were measured.Results: Both the obstructive domain of the Standardized Cosmesis and Health Nasal Outcomes Survey and the cosmetic domain showed a high internal consistency, alpha 0.94 and 0.95, respectively. The Standardized Cosmesis and Health Nasal Outcomes Survey was reliable showing very strong test–retest correlations of 0.93 for Standardized Cosmesis and Health Nasal Outcomes Survey-obstructive domain and 0.94 for Standardized Cosmesis and Health Nasal Outcomes Survey-cosmetic domain, respectively. The Wilcoxon rank-sum test showed a significant difference between cases and controls for the Standardized Cosmesis and Health Nasal Outcomes Survey-cosmetic domain (P =.0001) but not for the Standardized Cosmesis and Health Nasal Outcomes Survey-obstructive domain (P =.14). Exploratory factor analysis showed unidimensionality for both the Standardized Cosmesis and Health Nasal Outcomes Survey-cosmetic domain and the Standardized Cosmesis and Health Nasal Outcomes Survey-obstructive domain.Conclusion: The Standardized Cosmesis and Health Nasal Outcomes Survey was successfully translated, culturally adopted, and validated for its use in a Dutch-speaking population of rhinoplasty patients.</p

Vestibular Infant Screening (VIS)–Flanders : results after 1.5 years of vestibular screening in hearing-impaired children

Due to the close anatomical relationship between the auditory and vestibular end organs, hearing-impaired children have a higher risk for vestibular dysfunction, which can affect their (motor) development. Unfortunately, vestibular dysfunction often goes unnoticed, as vestibular assessment in these children is not standard of care nowadays. To timely detect vestibular dysfunction, the Vestibular Infant Screening–Flanders (VIS–Flanders) project has implemented a basic vestibular screening test for hearing-impaired infants in Flanders (Belgium) with a participation rate of 86.7% during the first year and a half. The cervical Vestibular Evoked Myogenic Potentials (cVEMP) test was applied as vestibular screening tool to map the occurrence of vestibular (mainly saccular) dysfunction in this population. At the age of 6 months, 184 infants were screened. No refers on vestibular screening were observed in infants with permanent conductive hearing loss. In infants with permanent sensorineural hearing loss, a cVEMP refer rate of 9.5% was observed. Failure was significantly more common in infants with severe-profound compared to those with mild-moderate sensorineural hearing loss (risk ratio = 9.8). Since this is the first regional study with a large sample size and successful participation rate, the VIS–Flanders project aims to set an example for other regions worldwide